(Q42990471)

12 November 2017

Hepatitis C: The role of new interferons in the era of STAT-C. (English)

1 reference

12 November 2017

2

Patrick Marcellin

1 reference

12 November 2017

Rami Moucari

1

1 reference

PubMed ID

19713984

12 November 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

12 November 2017

1 reference

12 November 2017

6

1 reference

12 November 2017

9

1 reference

12 November 2017

509-511

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2009.141

12 November 2017

0 references

cites work

Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to pegylated interferon alfa-2b and ribavirin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.141

Hepatitis B and hepatitis C in 2009.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19713984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2009.141

1 reference

release_bs6ipgqtoncaritl3vjtxjrpfa

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bs6ipgqtoncaritl3vjtxjrpfa

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19713984

1 reference

PubMed ID

19713984